How have KVUE shares performed this year?

Kenvue's stock was trading at $21.53 on January 1st, 2024. Since then, KVUE stock has increased by 6.2% and is now trading at $22.86. View the best growth stocks for 2024 here .

How were Kenvue's earnings last quarter?

Kenvue Inc. (NYSE:KVUE) announced its earnings results on Tuesday, August, 6th. The company reported $0.32 EPS for the quarter, beating analysts' consensus estimates of $0.28 by $0.04. The business's quarterly revenue was down .3% compared to the same quarter last year.

Kenvue (KVUE) raised $3.3 billion in an initial public offering on Thursday, May 4th 2023. The company issued 151,200,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Securities, Citigroup, Deutsche Bank Securities, BNP PARIBAS, HSBC, RBC Capital Markets and UBS Investment Bank served as the underwriters for the IPO.

Who are Kenvue's major shareholders?

Top institutional investors of Kenvue include Massachusetts Financial Services Co. MA (4.17%), Bank of New York Mellon Corp (2.27%), American Century Companies Inc. (1.43%) and Van ECK Associates Corp (1.07%). View institutional ownership trends .

How do I buy shares of Kenvue?

Shares of KVUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:KVUE

Kenvue (KVUE) Stock Price, News & Analysis

$22.86

+0.35 (+1.55%)

(As of 09/6/2024 ET)

Compare

Today's Range: $22.50
▼
$23.00
50-Day Range: $17.69
▼
$22.86
52-Week Range: $17.67
▼
$23.00

Volume: 18.88 million shs
Average Volume: 18.60 million shs
Market Capitalization: $43.77 billion

P/E Ratio: 29.31
Dividend Yield: 3.59%
Price Target: $22.64

Get Kenvue alerts:

Kenvue MarketRank™ Stock Analysis

Analyst Rating: Hold
2.33 Rating Score
Upside/Downside: 6.2% Downside
$21.44 Price Target
Short Interest: Healthy
2.34% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.69
Based on 19 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 14.81%
From $1.08 to $1.24 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.66 out of 5 stars

Consumer Staples Sector

85th out of 136 stocks

Toilet Preparations Industry

7th out of 13 stocks

2.1

Analyst's Opinion

Consensus Rating
Kenvue has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 3 buy ratings, 6 hold ratings, and 1 sell rating.
Amount of Analyst Coverage
Kenvue has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.
Read more about Kenvue's stock forecast and price target.

3.0

Short Interest

Percentage of Shares Shorted
2.34% of the float of Kenvue has been sold short.
Short Interest Ratio / Days to Cover
Kenvue has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Kenvue has recently increased by 47.93%, indicating that investor sentiment is decreasing significantly.

2.5

Dividend Strength

Dividend Leadership
Kenvue is a leading dividend payer. It pays a dividend yield of 3.64%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Kenvue does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Kenvue is 105.13%. Payout ratios above 75% are not desirable because they may not be sustainable.
Dividend Sustainability
Based on earnings estimates, Kenvue will have a dividend payout ratio of 66.13% next year. This indicates that Kenvue will be able to sustain or increase its dividend.
Read more about Kenvue's dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for KVUE.

2.6

News and Social Media Coverage

News Sentiment
Kenvue has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.
News Coverage This Week
MarketBeat has tracked 19 news articles for Kenvue this week, compared to 12 articles on an average week.
Search Interest
39 people have searched for KVUE on MarketBeat in the last 30 days. This is an increase of 15% compared to the previous 30 days.
MarketBeat Follows
Only 10 people have added Kenvue to their MarketBeat watchlist in the last 30 days. This is a decrease of -9% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Kenvue insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.17% of the stock of Kenvue is held by insiders.
Percentage Held by Institutions
97.64% of the stock of Kenvue is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Read more about Kenvue's insider trading history.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Kenvue are expected to grow by 14.81% in the coming year, from $1.08 to $1.24 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Kenvue is 29.31, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.71.
Price to Earnings Ratio vs. Sector
The P/E ratio of Kenvue is 29.31, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 22.24.
Price to Earnings Growth Ratio
Kenvue has a PEG Ratio of 2.76. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Kenvue has a P/B Ratio of 4.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
Read more about Kenvue's valuation and earnings.

See Top Rated MarketRank™ Stocks Here

Ad Porter & Company

Why billionaires are wiring money to abandoned towns

A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.

Click here for my exclusive video

About Kenvue Stock (NYSE:KVUE)

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

KVUE Stock Price History

30 days | 90 days | 365 days | Advanced Chart

KVUE Stock News Headlines

August 16, 2024 | marketbeat.com

Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon (KVUE)

These three stocks have a long history of increasing their dividends and are likely to benefit from sector rotation on expectations of lower interest rates

September 7 at 1:15 AM | americanbankingnews.com

Research Analysts Set Expectations for Kenvue Inc.'s Q3 2024 Earnings (NYSE:KVUE)

September 7, 2024 | Golden Crest (Ad)

Biden’s Capital Gains Tax to Devastate Savings!

Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.

September 6 at 4:13 AM | ca.finance.yahoo.com

KVUE Jun 2025 25.000 put

September 4 at 12:28 PM | ca.finance.yahoo.com

KVUE Sep 2024 25.000 call

September 4 at 12:28 PM | ca.finance.yahoo.com

KVUE Jun 2025 25.000 call

September 1, 2024 | fool.com

Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.

September 1, 2024 | benzinga.com

Kenvue (NYSE:KVUE) Stock Quotes, Forecast and News Summary

September 7, 2024 | Golden Crest (Ad)

Biden’s Capital Gains Tax to Devastate Savings!

Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.

August 30, 2024 | benzinga.com

Unpacking the Latest Options Trading Trends in Kenvue

August 30, 2024 | benzinga.com

Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps

August 28, 2024 | americanbankingnews.com

Kenvue Inc. (NYSE:KVUE) Receives $22.64 Consensus Target Price from Analysts

August 28, 2024 | finance.yahoo.com

Here's How You Can Earn $100 In Passive Income By Investing In Kenvue Stock

August 28, 2024 | theglobeandmail.com

Tylenol maker Kenvue defeats U.S. lawsuit over labelling on ‘Rapid Release’ gelcaps

August 26, 2024 | finance.yahoo.com

KVUE Aug 2024 25.500 call (KVUE240830C00025500)

August 23, 2024 | businesswire.com

Kenvue Announces Participation in the Barclays Global Consumer Staples Conference

August 22, 2024 | 247wallst.com

Passive Income Matters: These 3 Stocks Are Perennial Dividend Growers Worth Buying

August 21, 2024 | reuters.com

Tylenol ADHD lawsuits cannot go forward, judge rules

See More Headlines

Receive KVUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kenvue and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/06/2024
Ex-Dividend for 8/28 Dividend: 8/14/2024
Dividend Payable: 8/28/2024
Today: 9/07/2024
Next Earnings (Estimated): 10/24/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Consumer Staples
Industry: Toilet preparations
Sub-Industry: Consumer Goods
Current Symbol: NYSE:KVUE
CUSIP: N/A
CIK: 1944048
Web: www.kenvue.com
Phone: (732) 524-0400
Fax: N/A
Employees: 22,000
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $21.44
High Stock Price Target: $24.00
Low Stock Price Target: $18.00
Potential Upside/Downside: -1.0%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.78
Trailing P/E Ratio: 29.31
Forward P/E Ratio: 21.17
P/E Growth: 2.76
Net Income: $1.66 billion
Net Margins: 7.23%
Pretax Margin: 9.27%
Return on Equity: 21.80%
Return on Assets: 8.61%

Debt

Debt-to-Equity Ratio: 0.69
Current Ratio: 0.99
Quick Ratio: 0.68

Sales & Book Value

Annual Sales: $15.48 billion
Price / Sales: 2.83
Cash Flow: $1.64 per share
Price / Cash Flow: 13.96
Book Value: $5.31 per share
Price / Book: 4.31

Miscellaneous

Outstanding Shares: 1,914,815,000
Free Float: 1,911,560,000
Market Cap: $43.77 billion
Optionable: Optionable
Beta: 1.38

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Thibaut Mongon (Age 53)
CEO & Director
Comp: $4.79M
Mr. Paul Ruh (Age 56)
Chief Financial Officer
Comp: $2.33M
Ms. Meredith Stevens (Age 61)
Chief Operations Officer
Comp: $1.84M
Mr. Carlton Lawson (Age 55)
Group President of EMEA & Latin America
Comp: $2.28M
Ms. Ellie Bing Xie (Age 54)
Group President of Asia Pacific
Comp: $2.94M
Ms. Heather R. Howlett (Age 46)
Chief Accounting Officer
Mr. Bernardo Tavares (Age 56)
Chief Data & Technology Officer
Dr. Caroline Tillett (Age 52)
Chief Scientific Officer
Ms. Tina Romani
Head of Investor Relations
Mr. Matthew Orlando (Age 47)
General Counsel

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

Should I Buy Kenvue Stock? KVUE Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Kenvue Inc.:

Kenvue Inc. recently increased its dividend from $0.20 to $0.205 per share, indicating a positive outlook on the company's financial health and commitment to rewarding shareholders.
Analysts have given Kenvue Inc. a consensus rating of "Hold" with a target price of $22.64, suggesting stability and potential for growth in the stock.
Kenvue Inc. reported earnings per share of $0.32 for the quarter, surpassing analysts' estimates by $0.04, showcasing strong financial performance.
The company has a diverse product portfolio operating in three segments: Self Care, Skin Health and Beauty, and Essential Health, providing resilience and potential for revenue growth.
With a market capitalization of $40.25 billion and a P/E ratio of 26.95, Kenvue Inc. presents itself as a solid investment opportunity in the consumer health sector.

Cons

Investors should be bearish about investing in Kenvue Inc. for these reasons:

Despite positive aspects, Kenvue Inc. has received mixed ratings from analysts, with one sell rating, seven hold ratings, and five buy ratings, indicating uncertainty in market sentiment.
The stock price of Kenvue Inc. has experienced fluctuations, trading at $21.02 on the latest trading day, which may pose risks for short-term investors.
Kenvue Inc.'s dividend payout ratio is currently at 105.13%, suggesting a high proportion of earnings being distributed as dividends, potentially limiting reinvestment for growth.
The company's revenue was down .3% on a year-over-year basis, indicating a slight decline in top-line performance that investors should consider.
With a beta of 1.38, Kenvue Inc. is relatively more volatile compared to the market average, which could lead to higher fluctuations in stock price.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, September 3, 2024. Please send any questions or comments about these Kenvue pros and cons to contact@marketbeat.com.

KVUE Stock Analysis - Frequently Asked Questions

How have KVUE shares performed this year?: Kenvue's stock was trading at $21.53 on January 1st, 2024. Since then, KVUE stock has increased by 6.2% and is now trading at $22.86.
View the best growth stocks for 2024 here.
How were Kenvue's earnings last quarter?: Kenvue Inc. (NYSE:KVUE) announced its earnings results on Tuesday, August, 6th. The company reported $0.32 EPS for the quarter, beating analysts' consensus estimates of $0.28 by $0.04. The business's quarterly revenue was down .3% compared to the same quarter last year.
When did Kenvue IPO?: Kenvue (KVUE) raised $3.3 billion in an initial public offering on Thursday, May 4th 2023. The company issued 151,200,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Securities, Citigroup, Deutsche Bank Securities, BNP PARIBAS, HSBC, RBC Capital Markets and UBS Investment Bank served as the underwriters for the IPO.
Who are Kenvue's major shareholders?: Top institutional investors of Kenvue include Massachusetts Financial Services Co. MA (4.17%), Bank of New York Mellon Corp (2.27%), American Century Companies Inc. (1.43%) and Van ECK Associates Corp (1.07%).
View institutional ownership trends.
How do I buy shares of Kenvue?: Shares of KVUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:KVUE) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Kenvue (KVUE) Stock Price, News & Analysis

Kenvue MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Consensus Rating

Amount of Analyst Coverage

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Dividend Leadership

Dividend Growth

Dividend Coverage

Dividend Sustainability

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Insider Buying vs. Insider Selling

Percentage Held by Insiders

Percentage Held by Institutions

Earnings and Valuation

Earnings Growth

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Earnings Growth Ratio

Price to Book Value per Share Ratio